|4Jun 25, 6:22 PM ET

CHAUDHURI BHASKAR 4

4 · Tarsus Pharmaceuticals, Inc. · Filed Jun 25, 2024

Insider Transaction Report

Form 4
Period: 2024-06-24
Transactions
  • Exercise/Conversion

    Common Stock

    2024-06-24+3,3505,350 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-06-243,3500 total
    Common Stock (3,350 underlying)
Footnotes (3)
  • [F1]The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock.
  • [F2]Each RSU represents a contingent right to receive one share of the Company's common stock.
  • [F3]RSUs granted on June 22, 2023, in connection with the Reporting Person's service as a non-employee director as of the Company's 2023 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service.

Documents

1 file
  • 4
    wk-form4_1719354137.xmlPrimary

    FORM 4